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Abstract
Conflict of Interest—None declared.
Background—Intracranial atherosclerotic disease (ICAD) is the most frequent subtype of ischemic stroke
globally. It is important to describe the determinants of early ICAD as a strategy to prevent strokes from
clinically evident and progressive ICAD. Our objective is to report the determinants of asymptomatic
ICAD by linking the presence or absence of ICAD on magnetic resonance angiogram (MRA) with detailed
risk assessment in asymptomatic adults.
Methods—This is an observational cross-sectional analytical study. We plan to recruit 200 adult participants from the radiology departments of two tertiary care centers of Karachi, Pakistan. The participants will
first be screened for the absence of stroke symptoms via the Questionnaire for Verifying Stroke Free Status
(QVSFS). QVSFS negative will be participants will be eligible. After written informed consent, participants will undergo detailed medical, sociodemographic, lifestyle, and anthropometric evaluation by a
detailed interview. They will, in addition, undergo MRA to study the presence, degree, and distribution of
asymptomatic ICAD. All MRA scans will be reviewed centrally by vascular neurologists blinded to clinical
information. These images would be reviewed on DICOM Viewer 3.0 used for calculating the degree of
stenosis using Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) study defined criteria
employing electronic calipers. A sample size of 200 will achieve 80% power for detecting a minimum difference of 20% in the prevalence of exposure factors (medical and lifestyle) between asymptomatic ICAD
Published February, 2015.
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Figure 1. Study flow diagram.

positive and ICAD negative persons. This study will generate regional data on risks for ICAD development
and prevention in a high-risk susceptible population.
Study ID: NCT02072876
Key Words
Stroke; Asymptomatic Intracranial Stenosis; Developing Countries; Prevention; Sociodemographic Risk
Factors; Epidemiology; Radiology

Background
Stroke is the emerging noncommunicable disease epidemic of the developing world. Studies from Pakistan,
the sixth most populous nation in the world [1], report
that the lifetime prevalence of cerebrovascular disease
(CVD) is one in four (25%) over the age of 35 years [2].
Two thirds of all stroke deaths now occur in low- and

middle-income countries that report a 100% increase in
the incidence of stroke in the last four decades [3].
Intracranial atherosclerotic disease (ICAD), which is
progressive narrowing of the arteries at the base of the
brain, is a major cause of ischemic stroke, with higher
prevalence in Asian, African American, and Hispanic
individuals as compared with Caucasians [4]. ICAD
causes about 30%–50% of ischemic strokes among
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patients of Asian ancestry, by contrast, approximately
8%–9% of strokes are attributable to ICAD in Caucasians [5].The Karachi Intracranial Stenosis study (KISS),
a hospital-based case–control study for symptomatic
ICAD, reported that 80% of vessels studied in stroke
patients had significant asymptomatic stenosis (>70%)
[6].
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Numerically, symptomatic ICAD is the most common
mechanism of stroke in the world, given that a large part
of the world’s population lives in Asia. Clinical ICAD is
likely to be preceded by a period of silent atherosclerotic
narrowing and plaque formation. At the point of either
critical stenosis, or plaque destabilization, strokes result
from loss of blood supply, overlying thrombosis and/or
arterial embolization [7].Clinical ICAD is an aggressive
disease. The rate of stroke recurrence is high (up to
18%–24% annually) [4], [8]. Current interventions for
clinically active ICAD are difficult to implement in
regions that bear the brunt of ICAD [9]–[11]. Our overarching rationale is that early detection of asymptomatic
ICAD and identification of its risk factors may allow
regionally implementable therapeutic interventions at a
lower cost and greater efficacy. We feel this is important, since this is a unique population subject to an
increased risk of stroke mortality [12] that has increased
in the last decade and is a call for action.

Objective
Our objective is to study the clinical, lifestyle, dietary,
and psychosocial determinants of asymptomatic ICAD
in clinically normal adults. As an additional secondary
objective, we will also study the frequency of ICADassociated findings on magnetic resonance imaging
(MRI), e.g., brain volume reduction, silent brain infarcts,
and periventricular hyper intensities in patients diagnosed with asymptomatic ICAD on MRI brain. We
hypothesized that there is at least a 20% difference in
the proportion of clinical, lifestyle (dietary, physical
activity, obesity, smoking, and stress/depression), and
socioeconomic predictors among asymptomatic ICAD
patients than those with no ICAD.

Methods
Study Design
Analytical Cross-Sectional Observational Study (Figure
1, Flow Chart)
Study Setting
The study will be carried out at the radiology departments of two major tertiary care centers in Karachi,

Pakistan [Aga Khan University (AKU)], and Dow University of Health Sciences (DUHS). These major MRI
centers cover the bulk of MRI referrals from all over
Pakistan and cover all socioeconomic and ethnic strata.
AKU is a private not for profit academic international
center. The Dow University Radiology Center is a public sector, government funded, subsidized-at-cost center.
Both the centers have radiology departments equipped
with 1.5 Tesla MRI scanner facilities, which are open
24/7 for all patients (inpatients and outpatients). Since
both are based in Karachi, Pakistan’s largest city with a
mix of ethnicities, together they represent a microcosm
of Pakistan, and provide a wide spectrum of participants
that lends representativeness to the sample population.
Study Population
This study aims to recruit adult Pakistani patients > 18
years, with no previous clinical history of stroke (negative on QVSFS), presenting to the two tertiary care centers for MRI brain for indications other than stroke (e.g.,
nonspecific headache, sinusitis, primary epilepsy, and
primary dementia without stroke history) and consenting
for MRA, interview, and anthropometry.
Sample Size Estimation
We have calculated that a minimum sample size of 200
people will be required in order to achieve 80% power
for detecting a minimum difference of at least 20% in
the prevalence of exposure factors (medical and lifestyle) between asymptomatic ICAD positive and ICAD
negative persons, with the anticipated prevalence of all
exposure factors (medical: diabetes, hypertension, dyslipidemia, and heart disease; and lifestyle: dietary, physical activity, obesity, and stress) ranging from 4%–70%,
assuming a 1:3 ratio in patients with ICAD versus no
ICAD at a 5% level of significance.

Statistical Analysis
For continuous variables like age, weight, height, waist
circumference and body mass index (BMI), mean and
standard deviations (SDs) will be calculated. For categorical variables like gender, ethnicity, education, marital
status, income, occupation, ICAD, clinical and lifestyle
factors (diabetes, hypertension, dyslipidemia, CVD,
tobacco use, obesity, diet, and depression), brain atrophy, silent brain infarcts, and perventricular lucencies,
proportions will be calculated.
BMI will be calculated by dividing weight in kilogram
by the square of height in square meters. BMI was
expressed as mean and SD as well as five categories
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defined using the South Asian cutoffs [13]. Waist circumference was also divided into categories using cutoffs defined specifically for Asians [14].

•

Patients in whom MRI prolongation for 5
minutes can be harmful for the patient (Anesthesia, claustrophobia, sedation, and so on)

The independent contribution of any risk factor to ICAD
will be examined in the univariate Cox proportional hazards model, which was used to calculate prevalence
ratios. Point estimates and 95% confidence intervals
(CIs) were calculated from the regression coefficients.
The p value of the Wald statistics for each explanatory
variable was used for assessing its coefficient with significance of 0.25.

•

Any clear contraindications to MRI, e.g., pacemakers, metallic valves, patient is not an MRI
candidate
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In order to compute the statistically adjusted prevalence
ratios (PR), multivariable Cox regression analysis will
be done. Variables will be introduced as continuous or
categorical variables, as indicated in results. With categorical variables, the lowest or opposite category will
serve as the reference group. All the variables significant
at univariable level and/or the variables with previously
known associations with the outcome (ICAD) will be
entered into the model in a block wise fashion. The level
of significance of ≤0.05 was set for multivariable analysis. Significance of each individual independent variable
was assessed by its Cl, Wald statistic and the change in
the −2 log-likelihood. Insignificant variables (p > 0.05)
were removed one by one from the model with the most
insignificant first after checking their interaction. A final
model was recalculated as the most parsimonious version, including only significant variables and interpreted
by using adjusted PRs and their 95% CIs. Statistical
analyses were conducted using the Statistical Package
for Social Sciences (SPSS), Version 19.

Study Inclusion and Exclusion
Criteria
Inclusion Criteria:
•

Adult Pakistani men and women ≥18 years of
age getting MRI brain for any indication other
than stroke.

•

Permanent residents of Pakistan for at least 1
year.

•

No prior history of stroke confirmed by screening with QVSFS. QVSFS negative.

•

Able to give written informed consent.

Exclusion Criteria:
•

QVSFS positive

•

Severe disability, life expectancy less than 6
months at enrollment

Study Procedures
Prefield Pilot
The questionnaire has been translated from English into
Urdu. The aim was not to do a literal word to word
translation but to have conceptually equivalent items in
the Urdu version of the questionnaires as well as to
insert culturally acceptable terms particularly for the diet
questionnaire. Already the existing and validated Urdu
versions of Short International Physical Activity Questionnaire (IPAQ) and Self-Reporting Questionnaire
(SRQ) for depression [15] and tested Urdu version of
QVSFS will be used [2], [16], [17]. The rest of the questionnaire has been translated into Urdu by the principal
investigator (PI) directly for quality and conceptualization. The Urdu version of the questionnaire will then be
pretested in the neurology clinic population (10% of the
sample size) to see its acceptability after which any
required changes in the phrasing of Urdu version of the
questionnaire will be done.
Hiring and Training Data Collectors
Before the start of the data collection process, the data
collectors will be given training on communication
skills through a two day long workshop conducted by
the PI. They will be introduced to the different tools
used in the questionnaire and their administration. They
will also be given training on how to perform anthropometric measurements. Along with this they will also be
given a copy of the Manual of operations (Additional
File 1) specifying pictorial methods for anthropometric
measurements. A standard method of data reporting will
be communicated to all. No box or space in the form is
to be left blank and if left blank the reason has to be
specified in the form. Training will also include visit to
the specified settings to orient the data collectors to the
place and introduce them to the relevant people whom
they might encounter during the data collection process.
The data collectors will be taught to keep records of all
patients they approach whether they get enrolled in the
study or not. Once training is complete the data collectors will be cross-checked by the PI in the field at the
site for audit and feedback.
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Data Collection Procedures

Questionnaire
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Nonprobability purposive sampling will be used to
recruit consecutive patients prospectively from the two
hospital sites. Data collectors at the two field sites will
be responsible for first screening out all outpatients who
come for MRI brain, via QVSFS, for presence of stroke
and then take informed consent and enroll them in the
study. Once the participant is recruited in the study, the
research officers will collect history of medical and lifestyle factors on a SRQ consisting of seven sections (as
detailed below) followed by height, weight, and waist
measurements and imaging study. These images will
then be collected on compact disks (CDs) by the designated research officers for centralized image viewing.
All data forms coming from the field shall be checked
by the PI and discrepant or unfilled forms will be
returned for completion. To ensure data accuracy, we
will perform double data entry by a data entry officer
who has been trained by the PI in reading the filled data
forms using the data code book. (Additional File 2
(Questionnaire)).

Data Collection Tools and Variable
Definition
Following data collection tools will be used in this
study:
I.

Questionnaire (Additional File 2) consisting of
eight sections is as follows:
1.

Screening questionnaire
(QVSFS) [2], [6]

for

stroke

2.

Demographic and Socioeconomic Information via World Bank Wealth Index [18]

3.

Clinical risk factors

4.

Tobacco usage [19]

5.

IPAQ short form for physical activity
assessment (Additional File 3) [20]

6.

Food frequency Questionnaire (FFQ) [21],
[22]

7.

Self-Reporting Questionnaire (SRQ) for
depression [15], [23]

8.

Anthropometric measurements [13]

II. MRI Brain with MRA
III. Data Collection Form (DCF) (Additional File
3) for detecting intracranial stenosis [24], [25]

The questionnaire consists of eight sections. Section I is
the stroke free status determining questionnaire, which
is an important inclusion criterion for the study. It is an
eight-item structured questionnaire originally designed
to identify study subjects, who are free of symptomatic
cerebrovascular disease, with a high sensitivity (0.97)
and moderate specificity (0.60) for detecting stroke [26].
It has been used in previous studies on Pakistani population and has a good detection rate [6]. Section II is the
demographic and socioeconomic information section. It
has 10 items that collect information about age, sex, ethnicity, education, and marital status and five questions
regarding income, occupation, and number of household
members and household assets. For assessing household
assets, the Assets Questionnaire developed by the World
Bank for developing countries will be used [18]. The
questionnaire has been modified keeping in view the
study population. It consists of 19 items inquiring about
the presence or absence of household assets, and the
number of persons sharing a room. Section III inquires
about clinical risk factors, e.g., diabetes, hypertension,
dyslipidemia, heart attack, atrial fibrillation, and history
of coronary bypass surgery. Hypertension is defined as
systolic blood pressure > 140 mmHg or diastolic blood
pressure > 90 mmHg, or those with a clear hypertension
medical record, or record of antihypertensive drugs
usage [27]. Subjects with diabetes mellitus are those
with documented diabetes in the medical record, or
those having a random glucose level of >11.1 mmol/L
(200 mg/dl) or those who are on medicines for diabetes
treatment [28]. Dyslipidemia is defined as total cholesterol >200 mg/dl or LDL >160 mg/dl or those taking
lipid-lowering drugs [29], [30]. IHD is defined as a
known history of myocardial infarction or angina [29].
Section IV has the World Health Organization (WHO)
stepwise approach to surveillance (STEPS) questionnaire for tobacco usage [19]. It has 13 items collecting
self-reported information of current or past smoking and
smokeless tobacco use with durations. Current users are
defined as individuals who have been using any kind of
tobacco in the previous 12 months. Former users are
those who have quit more than a year earlier. Section V
is the IPAQ short form. It has seven items that collect
information regarding time spent in vigorous, moderate
physical activity, walking, and sitting during the last
week [31]. Section VI is the dietary questionnaire that
collects information on the daily, weekly, and monthly
consumption of food items and their quantity using a
Food Frequency Questionnaire designed especially for
the study keeping in mind the culinary pattern of the
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common Pakistani. It has 11 sections collecting information on 62 items.(Bread, Cereals, dairy products, Rice,
lentils, meat ,Bar BQ, Curries, Fish, Fruits and vegetables and bakery items) [21]. Section VII is the SRQ for
depression [15]. This standardized screening instrument
measures psychological and somatic symptoms associated with depression through 20 items. Each item has a
yes/no answer. The time span refers to the individual's
feelings over the past 30 days. Each item is scored 0 or
1. The maximum score is therefore 20. Its validity has
been tested in Pakistani population and found to have
good psychometric properties with sensitivity of 78%
and specificity of 81% [32].
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Section VIII is the anthropometric measurements section. This includes measurement of body weight of the
individual in kilograms and height and waist measurement in centimeters to calculate BMI. These anthropometric indices are regarded as the measurement of general and central obesity. For categorizing BMI, WHO’s
recommendations for Asian population will be used.
According to this classification, ≤18.5 kg/m2is underweight, 18.6–22.9 is normal weight, 23–24.9 is pre overweight, 25–29.9 is overweight, and >30 kg/m2 is obese
[13].
Waist circumferences of ≥90 cm in men and ≥80 cm in
women have been taken as cutoffs for increased risk of
metabolic consequences [14].
We presume the questionnaire will take around 30
minutes for administration.
Section II is the phase where the patient will undergo
MRI brain along with an additional 5 minutes MRA
without contrast administration.
Section III consists of the Questionnaire for documenting intracranial stenosis. It has seven questions regarding brain tissue volume, periventricular lucencies, old
vascular lesions, and nonstroke lesions along with a
table documenting the degree of stenosis in each cerebral vessel. Information will be collected for a total of
19 vessels per scan. A standardized MRI reading form
adapted from the work of J Wardlaw will be used [33]–
[38].

MRA Evaluation of Intracranial
Stenosis
This is defined as any artery (internal carotid artery,
middle cerebral artery, anterior cerebral artery, posterior
cerebral artery, basilar artery, and vertebral artery) hav-
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ing >25% stenosis on MRA. An internationally standardized equation will be used to calculate the degree of
stenosis. This method has also been used successfully in
a Pakistani study [39] to measure symptomatic intracranial stenosis.
Percent stenosis = [1 − (Dstenosis/Dnormal) × 100], where
Dstenosis is the diameter of the artery at the site of the
most severe stenosis, and Dnormal = diameter of the
proximal normal artery [40].
Special freely available software DICOM Viewer 3.1
will be used to save all MRI images. It allows zooming,
panning, measurements, annotations, and segmentation
of the images. It has the ability to rotate (90°, 180°) and
flip (horizontal, vertical) images. It also provides one
with angle values, which helps in measuring stenosis
around corners. All opened images can be reported
simultaneously. All MRI CDs will be reviewed by a vascular neurologist and radiologist team intracranial occlusive lesions will be rated by giving them 1 of 5 grades
depending on the narrowness of the arteries [41].
•

<25%, Atherosclerotic irregularity

•

25%–49% reduction as mild stenosis

•

50%–74% reduction as moderate stenosis

•

75%–99% reduction as severe stenosis

•

No opening will be graded as complete occlusion

Additionally, the MRI brain will also be viewed for the
presence of brain atrophy, periventricular lucencies, old
strokes and nonstroke lesions, and coded on a standardized form [33], [41], [42].

Ethical Concerns
The study protocol has been approved by the Ethical
Review Committees (ERC) of both participating centers.
(ERC number 2327 CHS ERC 12, and IRB 360/DUHs
2012). All participants will provide a written informed
consent. All MRA scans are reviewed within 24 hours
by radiology teams with a provision in the study to
report any critical, life threatening incidental findings
like aneurysms to the referring physician and provision
of urgent referral to facilitate care. In addition, all key
study and field staff received training in Neuroethics,
Good Clinical Practice (GCP), informed consent procedures, and human subject’s protection in research.

Discussion
This study will demonstrate the distribution and determinants of ICAD in otherwise normal asymptomatic
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Pakistanis presenting for MRI without a history of prior
stroke. Available international data reports ICAD prevalence of 4%–29% in high-risk asymptomatic subjects
[43]–[45]. The range of ICAD varies from 3% to 29.6%
depending on the modality used; cutoffs and risk profiles of population. Most of these previous studies [46]–
[54] have preferentially selected high-risk individuals to
study the prevalence of asymptomatic ICAD, however
none have been performed in Pakistan and most have
used transcranial doppler (TCD) or a single artery
instead of a more holistic approach. Other serious limitations of previous investigations are inappropriate recruitment strategies, evaluating only one artery, or choosing
to report only advanced stenosis, or selecting high-risk
patients likely to have strokes. Information on all lifestyle predictors like exercise, diet, smoking, obesity,
stress of ICAD have to date not been described,
although known risks like hypertension, diabetes, and
previous stroke have been inconsistently reported.

tension, diabetes, and so on. This approach for ICAD is
comprehensive. This knowledge will inform both global
and local stroke preventive strategies of the most common cause of stroke in the world.

List of abbreviations
ICAD

Intracranial Atherosclerotic Disease

QVSFS

Questionnaire for Verifying Stroke Free
Status

MRA

Magnetic Resonance Angiogram

WASID

Warfarin–Aspirin Symptomatic Intracranial Disease

CVD

Cerebrovascular disease

MRI

Magnetic Resonance Imaging

This study plans to recruit relatively risk free individuals
and hopes to uncover social and demographic determinants of ICAD that have not been previously investigated. Regional comparable data for risk free subjects is
sparse. Since we are using a sensitive modality like
MRI, we hope to accurately detect the presence of ICAD
better as compared to studies reported that have
employed TCD for the same.

KISS

Karachi Intracranial stenosis study

AKU

Aga Khan University

DUHS

Dow University of Health Sciences

BMI

Body Mass Index

SD

Standard Deviations

We feel that our study design is valuable for the following reasons. We will not select high-risk participants
with hypertension, diabetes, and so on; therefore, biasing our study toward conventional risk factors alone. A
detailed review of asymptomatic status shall be done
using a questionnaire (QVSFS), which has been used
internationally to rule out clinical stroke with 95% sensitivity and specificity [55]. This has been previously used
in Pakistan [2]. In addition, all our risk factor assessment tools have been locally validated [15], [24]. Rigorous training will be given to all data collectors, so that
the same protocol is implemented at all centers. 24/7
back up was available for any participant intake, where
there was a question about stroke, by stroke neurologists
further adding clarity to participant eligibility. Same
diagnostic MRI, i.e., 1.5 Tesla was used at both the centers thus reducing diagnostic/detection bias. Centralized
coding system for MRA and specialized software was
used for storing and image viewing with expert back up.
This study assessed a number of novel risk factors for
ICAD like sociodemographic factors, physical activity,
diet, and depression, which have not been explored previously, i.e., a whole person approach rather than focusing on only traditional vascular risk factors like hyper-

PR

Prevalence Ratios

CI

Confidence Interval

SPSS

Statistical Package for Social Sciences

IPAQ

International Physical Activity Questionnaire

SRQ

Self-Reporting Questionnaire

PI

Principal Investigator

FFQ

Food frequency Questionnaire

DCF

Data Collection Form

WHO

World Health Organization

STEPS

Stepwise approach to surveillance

ERC

Ethical Review Committee

GCP

Good Clinical Practice

TCD

Transcranial Doppler
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